TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06457477

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 100mg/10ml/1bottle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NAs
Description: tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peg-IFNα-2b
Description: 180ug/0.5ml/1bottle
Study: NCT06011265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Myrbetriq 25Mg Extended-Release Tablet
Description: Participants take 4x 25mg Myrbetriq 25Mg Extended-Release Tablet orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants take empty capsule orally
Study: NCT06199765

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Needlestick Injury Prevention
Description: this intervention will be using needlestick injury prevention module which will involve lecture, demonstration, and role play

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Needlestick Injury Prevention
Description: this intervention will be using needlestick injury prevention module which will involve lecture, demonstration, and role play
Study: NCT06716541

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ERCP implantation of a biodegradable stent
Description: Endoscopic retrograde cholangiopancreatography (ERCP) with placement of a biodegradable stent to treat anastomotic biliary stricture (possibly combined with removal of previous plastic stents).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ERCP implantation of plastic stents
Description: Endoscopic retrograde cholangiopancreatography (ERCP) with placement of a plastic stent or multiple stents to treat anastomotic biliary stricture (possibly combined with removal of previous plastic stents).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ERCP implantation of plastic stents
Description: Endoscopic retrograde cholangiopancreatography (ERCP) with placement of a plastic stent or multiple stents to treat anastomotic biliary stricture (possibly combined with removal of previous plastic stents).
Study: NCT06717620

Intervention type: BEHAVIORAL
Intervention: Body composition before and after exams
Description: Measurement of body composition, eating habits, physical exercise in the same group of students before and after the exams
Study: NCT06718881

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: simulation application in a virtual reality environment
Description: In the project, theoretical lessons were given on preeclampsia, postpartum care, and condom counseling, each in a separate week. After each theoretical lesson, an application was made in the laboratory on the subject explained in the same week. The applications were made in the form of a simulation application in a virtual reality environment for the students in the experimental group.
Study: NCT05460650

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App Promoting Healthy Behaviours
Description: Women on the study will receive two months access to the app.
Study: NCT05632029

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: active laser
Description: 32 lupus prediabetic women will receive laser acupuncture (active laser) for one month (3 days week) on acupoint number 14 of GV meridian, acupoint number 4 and 11 of large intestine, acupoint number 34 of gall bladder meridian, acupoint number 3 of liver meridian, acupoint number 4, 12, and 9 of conception vessel meridian, acupoint number 40, 36, and 25 of stomach meridian, acupoint number 6 of spleen meridian, and acupoint number 5 of triple energizer meridian, laser will be applied for 1 min on every acupiont)

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham laser
Description: 32 lupus prediabetic women will receive laser acupuncture (sham laser, i.e power of device will be zero watt) for one month (3 days week) on acupoint number 14 of GV meridian, acupoint number 4 and 11 of large intestine, acupoint number 34 of gall bladder meridian, acupoint number 3 of liver meridian, acupoint number 4, 12, and 9 of conception vessel meridian, acupoint number 40, 36, and 25 of stomach meridian, acupoint number 6 of spleen meridian, and acupoint number 5 of triple energizer meridian, laser will be applied for 1 min on every acupiont)
Study: NCT05082298

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dental FearLess app
Description: Dental FearLess, is a self-administered psychoeducational intervention that will be accessed by participants via their personal smart device (In other words, this is an online application in which investigators present information about dental procedures. The user selects the procedure on which they would like information and then views a brief video on the selected procedure. It uses evidence-based tools to help participants manage their thoughts, feelings, and behavior related to dental fear to reduce fear during encounters with dental professionals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: In-Chair Treatment Protocol
Description: This session is a 1-hour-in-person Cognitive Behavioral Therapy (CBT) dental fear session by study staff at the dental office. Participants will practice managing their thoughts, behaviors, and/or feelings when exposed to stimuli that they report still fearing. After each practice situation, the mental health provider and participant discuss the disconfirmatory evidence generated by the situation.
Study: NCT04670224

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: QLB anesthesia
Description: The QLB is a bilateral locoregional anesthesia technique, performed after surgery, under general anesthesia and in right and then left lateral decubitus.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous anesthesia without QLB
Description: only intravenous anesthesia
Study: NCT06196918

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 MG
Description: Patients with postoperative lower extremity dyskinesia are treated with rivaroxaban (10 mg/day) and compression stockings until 1 month after surgery.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Patients with postoperative lower extremity dyskinesia are treated with placebo (10 mg/day) and compression stockings until 1 month after surgery.
Study: NCT06335420

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Carrot juice from Yellowstone carrots cultivars
Description: Consumption of 100 ml of carrot juice daily for 1 year

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo juice
Description: Consumption of 100 ml of placebo juice daily for 1 year
Study: NCT04776421

Intervention type: PROCEDURE
Intervention: Diverting ileostomy
Description: Diverting ileostomy
Study: NCT06041685

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: local warming
Description: local warming on the site for arterial catheterization using forced air warmer
Study: NCT05264558

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Xpert HCV Viral load finger stick point of care test (Cepheid)
Description: Xpert HCV VL Fingerstick is an in vitro reverse transcription polymerase chain reaction (RT-PCR) assay for the detection and quantification of Hepatitis C Virus (HCV) RNA in human venous and capillary fingerstick EDTA whole blood. Appropriate pre and post testing counselling will be provided to participants.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epclusa 400Mg-100Mg Tablet
Description: Same day HCV test and treatment

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of care
Description: Clinical services will receive additional education and have the option of providing incentives to attendees of service.

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of care
Description: Clinical services will receive additional education and have the option of providing incentives to attendees of service.
Study: NCT05755997

Intervention type: DRUG
Group type: OTHER
Intervention: Cerebrolysin
Description: 40 ml Cerebrolysin and 60 ml 0.9% NaCl per day for 4 days every month for 1 year

Intervention type: DRUG
Group type: OTHER
Intervention: Cerebrolysin
Description: 40 ml Cerebrolysin and 60 ml 0.9% NaCl per day for 4 days every month for 1 year

Intervention type: DRUG
Group type: OTHER
Intervention: 0.9 % NaCl
Description: 100 ml 0.9% NaCl per day for 4 days every month for 1 year

Intervention type: DRUG
Group type: OTHER
Intervention: 0.9 % NaCl
Description: 100 ml 0.9% NaCl per day for 4 days every month for 1 year
Study: NCT05505097

Intervention type: DRUG
Group type: OTHER
Intervention: Hydroxymethylquinoxalindioxyde
Description: Dioxidin (Hydroxymethylquinoxalindioxyde), solution for topical and external use, 0.25 mg/ml, applied as:~A - single rinsing of the oropharynx with 15.0 ml of the drug solution for at least 30 seconds B - single irrigation of the oropharynx by spraying the preparation 4 times with a spray nozzle C - irrigation of the skin on the back by spraying the preparation 4 times from a distance of 10 cm on 1% of the body surface using a spray nozzle and exposing the solution for 30 minutes or D - Dioxidin (Hydroxymethylquinoxalindioxyde), solution for infusion and external application, 5 mg/ml, single intravenous 5 mg/ml in 1 ml

Intervention type: DRUG
Group type: OTHER
Intervention: Hydroxymethylquinoxalindioxyde
Description: Dioxidin (Hydroxymethylquinoxalindioxyde), solution for topical and external use, 0.25 mg/ml, applied as:~A - single rinsing of the oropharynx with 15.0 ml of the drug solution for at least 30 seconds B - single irrigation of the oropharynx by spraying the preparation 4 times with a spray nozzle C - irrigation of the skin on the back by spraying the preparation 4 times from a distance of 10 cm on 1% of the body surface using a spray nozzle and exposing the solution for 30 minutes or D - Dioxidin (Hydroxymethylquinoxalindioxyde), solution for infusion and external application, 5 mg/ml, single intravenous 5 mg/ml in 1 ml

Intervention type: DRUG
Group type: OTHER
Intervention: Hydroxymethylquinoxalindioxyde
Description: Dioxidin (Hydroxymethylquinoxalindioxyde), solution for topical and external use, 0.25 mg/ml, applied as:~A - single rinsing of the oropharynx with 15.0 ml of the drug solution for at least 30 seconds B - single irrigation of the oropharynx by spraying the preparation 4 times with a spray nozzle C - irrigation of the skin on the back by spraying the preparation 4 times from a distance of 10 cm on 1% of the body surface using a spray nozzle and exposing the solution for 30 minutes or D - Dioxidin (Hydroxymethylquinoxalindioxyde), solution for infusion and external application, 5 mg/ml, single intravenous 5 mg/ml in 1 ml

Intervention type: DRUG
Group type: OTHER
Intervention: Hydroxymethylquinoxalindioxyde
Description: Dioxidin (Hydroxymethylquinoxalindioxyde), solution for topical and external use, 0.25 mg/ml, applied as:~A - single rinsing of the oropharynx with 15.0 ml of the drug solution for at least 30 seconds B - single irrigation of the oropharynx by spraying the preparation 4 times with a spray nozzle C - irrigation of the skin on the back by spraying the preparation 4 times from a distance of 10 cm on 1% of the body surface using a spray nozzle and exposing the solution for 30 minutes or D - Dioxidin (Hydroxymethylquinoxalindioxyde), solution for infusion and external application, 5 mg/ml, single intravenous 5 mg/ml in 1 ml
Study: NCT05736562

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ritual Epre Multimineral-Vitamin Supplement
Description: The Ritual Epre supplement is a commercially available multivitamin-mineral supplement designed for pregnant and lactating women.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control
Description: This is a customarily designed blank placebo provided by Ritual.
Study: NCT05340101

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ROGRESSIVE MUSCLE RELAXATION EXERCISE
Description: In the application, Relaxation Exercises CD Audio Recordings prepared by the Turkish Psychological Association were used. In the the second part of 30 minutes were explained with the sound of the PKGE stream and verbal instructions. Audio recordings in the second part were used in this study. In line with the PCGE sound recordings, each muscle group starting from the hands to the feet, and then the facial and whole body muscles were stretched for about 10 seconds. The exercise was applied by taking deep breaths while tensing each muscle group, and releasing this breath slowly during relaxation. The relaxation lasted 10-20 seconds before the next muscle group was stretched. In this way, the muscles groups in the hands, arms, neck, shoulders, chest, abdomen, hips, feet and fingers, face and whole body were voluntarily stretched and relaxed, respectively, and the students were relaxed.
Study: NCT06528210

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gonadotropin Releasing Hormone Agonists and Antagonists
Description: Given PO, IM, Sub-Q injection or Sub-Q implant

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bicalutamide
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo prostate biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary study

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation therapy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan
Study: NCT06224972

Intervention type: DEVICE
Intervention: Vlab
Description: The study is observational, there is no intervention.
Study: NCT05820009

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GORE® VIABIL® Biliary Endoprosthesis
Description: Endoscopic treatment of benign biliary stricture secondary to Chronic Pancreatitis with the GORE® VIABIL® Biliary Endoprosthesis.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GORE® VIABIL® Short Wire Biliary Endoprosthesis
Description: Endoscopic treatment of benign biliary stricture secondary to Chronic Pancreatitis with GORE® VIABIL® Short Wire Biliary Endoprosthesis
Study: NCT05411328

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality
Description: All children in the two groups received physical therapy protocol for 30 minutes in addition to virtual reality game traditional physical therapy group traditional physical therapy group

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality
Description: All children in the two groups received physical therapy protocol for 30 minutes in addition to virtual reality game traditional physical therapy group traditional physical therapy group
Study: NCT04676542

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: One hour of a beginning martial art class ,and a one hour walk at 4.0 mph pace.
Study: NCT05724017

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Street Games Intervention
Description: The children to be included in the study will be grouped in groups of 10 according to their age groups. Groups of 10 people consist of six sessions in total, two days a week for three weeks. Applications will be made in the school garden. In the meetings, games that attract the attention of children will be discussed, suitable games will be played, origami, painting and story sharing will be made. In the study, the independent variable street games intervention will be applied.
Study: NCT05128526

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise
Description: Short foot exercises without respiratory exercises

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: respiratory
Description: Short foot exercises with respiratory exercises
Study: NCT05271903

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MAMA Intervention
Description: The MAMA intervention will be based on PRONTO International's simulation training program to improve obstetric care delivery. The PRONTO curriculum is based on simulation and debrief of clinical scenarios, case-based learning, skills stations, and interactive teamwork and communication activities. Through the training, providers review and learn clinical skills related to obstetric care and emergencies, while reflecting on and practicing principles of respectful maternity care. The simulation exercises give providers and opportunity to act as the patient and develop empathy for the patient experience, and debriefing after simulation includes a reflection and discussion about RMC principles. The training will be two full days, followed by a refresher training in the clinical setting after one month.
Study: NCT04625361

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days
Study: NCT05275296

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intracranial stent for wide-necked aneurysms
Description: Intracranial stent for wide-necked aneurysms
Study: NCT05876455

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Subgingival Instrumentation
Description: On the conventional non-surgical periodontal therapy side, a power-driven piezo-electric ultrasonic scaling device with scaling tips will be used the majority of the time to debride subgingival biofilm and calculus, and manual standard Gracey curette instruments (Gracey curettes Hu-Friedy, Chicago, IL, USA) will be used to remove residual deposits from the root surface.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: minimally invasive non-surgical periodontal therapy
Description: minimally invasive non-surgical periodontal therapy will undergo careful scaling and root planing under magnification (use of 3.5 X magnification loupes) with mini curettes and using an ultrasonic device with specific thin and delicate tips. These instruments will be carefully inserted through the periodontal pocket of the affected tooth to reach the root surface for debridement. Caution will be taken to preserve the stability of soft tissues.
Study: NCT04592471

Intervention type: DEVICE
Intervention: kneeMID500-STRONG700
Description: At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) per device type (2 device types: Knee MID 500 and Knee STRONG 700) totalling 60 patients will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use a knee support device.

Intervention type: DEVICE
Intervention: kneeMID500-STRONG700
Description: At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) per device type (2 device types: Knee MID 500 and Knee STRONG 700) totalling 60 patients will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use a knee support device.
Study: NCT05778695

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
Description: Ketone ester (KE) dietary supplement (KetoneAid)

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
Description: Ketone ester (KE) dietary supplement (KetoneAid)

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
Description: Ketone ester (KE) dietary supplement (KetoneAid)
Study: NCT06012630

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultarsound
Description: Median nerve evaluation of participants with ultrasound

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultarsound
Description: Median nerve evaluation of participants with ultrasound

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultarsound
Description: Median nerve evaluation of participants with ultrasound
Study: NCT05637177

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Anging Wisely
Description: The program includes 11 meetings of two hours in a group of up to eight people. The sessions are held weekly. Each lesson is given a homework assignment. A total of 10 groups will take place.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: Music therapy sessions are held once a week for 60 minutes for 12 weeks. The maximum number of participants per group is 12. A total of 10 groups will be implemented.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminiscence therapy
Description: Reminiscence therapy sessions are held once a week for 60 minutes for 12 weeks. The maximum number of participants per group is 10. A total of 5 groups will be implemented.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive training
Description: Intervention cognitive training will take place once a week for 45 minutes for 20 weeks. Seniors can choose from two options: 1. group training full-time or home training (online) using the comprehensive training program MENTEM.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational activities
Description: Interventions in educational activities will run for one academic year. In total, seniors will attend 16 lectures in each educational module. The lectures will run 1 x 14 days for 90 minutes.